Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | MAOA | P21397 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | S100A4 | P26447 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | PTPRC | P08575 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.40 |
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.40 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2948518 | 0.97 | MAPT (0.38) | MAPTKMT2AMEN1LMNAMAOA | |
| SCHEMBL21359837 | 0.97 | MAPT (0.38) | MAPTKMT2AMEN1LMNAMAOA | |
| Bicarbonate SCHEMBL9542773 | 0.89 | NPSR1 (0.39) | MAPTKMT2AMEN1LMNAPOLB | |
| Phosphonic Acid SCHEMBL2459322 | 0.87 | MAPT (0.35) | MAPTKMT2AMEN1LMNAMAOA | |
| SCHEMBL9093165 | 0.83 | LMNA (0.37) | MAPTKMT2AMEN1LMNAMAOA | |
| SCHEMBL37950 | 0.80 | MEN1 (0.35) | MAPTKMT2AMEN1LMNAMAOA | |
| Benzylamine SCHEMBL7955985 | 0.79 | LOXL2 (0.58) | MAOASMN1; SMN2MAOBCYP1A2 | |
| Water SCHEMBL11357123 | 0.78 | APAF1 (0.33) | MAPTKMT2AMEN1LMNAMAOA | |
| SCHEMBL31241401 | 0.78 | APAF1 (0.33) | MAPTKMT2AMEN1LMNAMAOA | |
| SCHEMBL640436 | 0.78 | APAF1 (0.33) | MAPTKMT2AMEN1LMNAMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118047727-A | Method for preparing quinoxaline-2, 3-diketone compound by virtue of regioselective photocatalytic oxidation | 浙江工业大学台州研究院 | 2024-05-17 | — | — | CN | claimed |
| CN-116789610-A | Photocatalytic preparation method of quinoxaline-2, 3-diketone compound | 湖南科技学院 | 2023-09-22 | — | — | CN | claimed |
| US-20210395445-A1 | Heat and Aging Resistant Polyglycolide Copolymer and Composition Thereof | PUJING CHEMICAL INDUSTRY CO., LTD. (CN) | 2021-12-23 | — | — | US | claimed |
| EP-3873970-A1 | HEAT AND AGING RESISTANT POLYGLYCOLIDE COPOLYMER AND COMPOSITION THEREOF | Pujing Chemical Industry Co., Ltd (CN) | 2021-09-08 | — | — | EP | claimed |
| CN-112469763-A | High temperature and aging resistant polyglycolide copolymers and compositions thereof | 上海浦景化工技术股份有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-107337964-B | Colored liquid metal printing ink and preparation method thereof | 北京梦之墨科技有限公司 | 2020-07-07 | — | — | CN | claimed |
| WO-2019177117-A1 | DRUG FOR TREATING COUGH | 日本ケミファ株式会社 | 2019-09-19 | — | — | WO | claimed |
| US-20170072005-A1 | COMBINATIONS OF NMDAR MODULATING COMPOUNDS | UNIV NORTHWESTERN (US) | 2017-03-16 | — | — | US | claimed |
| EP-3139943-A1 | COMBINATIONS OF NMDAR MODULATING COMPOUNDS | Northwestern University (US) | 2017-03-15 | — | — | EP | claimed |
| EP-2983473-A2 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS Mountain Llc (US) | 2016-02-17 | — | — | EP | claimed |
| WO-1993008188-A1 | TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1993-04-29 | — | — | WO | claimed |
| EP-0518909-A1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE. | HOECHST AG (DE) | 1992-12-23 | — | — | EP | claimed |
| EP-0316649-B1 | WATER INSOLUBLE AZO COLOURING AGENTS, THEIR PREPARATION AND USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-22 | — | — | EP | claimed |
| WO-1991013941-A1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-09-19 | — | — | WO | claimed |
| US-5039528-A | EAA antagonists as anti-emetic drugs | OLNEY JOHN W (US) | 1991-08-13 | — | — | US | claimed |
| US-5026831-A | Water-insoluble disazo colorants having hetero-bicyclic methylene-active compounds as coupling component | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-06-25 | — | — | US | claimed |
| EP-0432994-A2 | Excitatory amino acid antagonists as anti-emetic drugs | Olney, John William (US) | 1991-06-19 | — | — | EP | claimed |
| EP-0424179-A2 | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration | Olney, John William (US) | 1991-04-24 | — | — | EP | claimed |
| EP-0224086-B1 | SUBSTITUTED BENZYL ETHERS | BAYER AG (DE) | 1990-10-24 | — | — | EP | claimed |
| EP-0316649-A2 | Water insoluble azo colouring agents, their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170072005-A1 | COMBINATIONS OF NMDAR MODULATING COMPOUNDS | GRIN1, GRIN2A, GRIN3A | MAPT 1043/4885KMT2A 1130/4885MEN1 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.